Framework for Brain-Derived Dimensions of Psychopathology

Area of Science:

• Neuroscience
• Psychiatry
• Genetics

Background:

• Current psychiatric diagnoses lack neurobiological definitions, hindering targeted therapy development.
• Research within diagnostic boundaries often yields inconsistent biological findings.
• Transdiagnostic studies frequently examine isolated symptoms, limiting a holistic understanding.

Purpose of the Study:

• To develop a framework grouping clinical symptoms based on their covariation and shared brain mechanisms.
• To align symptom clusters with existing diagnostic systems like ICD-10 and DSM-5.
• To establish a foundation for neurobiologically informed psychiatric research and treatment.

Main Methods:

• Utilized sparse generalized canonical correlation analysis to integrate clinical symptom data with seven brain imaging modalities.
• Employed two large cohorts: the population-based IMAGEN study and the cross-diagnostic STRATIFY/ESTRA samples.
• Developed and validated a predictive model for symptom features across different datasets and time points.

Main Results:

• Identified six cross-diagnostic psychopathology scores consistently associated with multimodal neuroimaging components.
• These scores represent dimensions such as excitability/impulsivity, depressive mood/distress, emotional/behavioral dysregulation, stress pathology, eating pathology, and social fear/avoidance.
• Demonstrated robust associations between these symptom dimensions and quantifiable neurobiological measures.

Conclusions:

• Successfully identified symptom groups of mental illness defined by distinct brain mechanisms.
• Enabled the characterization of psychopathology dimensions based on quantifiable neurobiological measures.
• This approach offers a pathway toward more precise and effective treatments for mental illnesses.